Bisphosphonates and cardiovascular risk in elderly patients with previous cardiovascular disease: a population-based nested case-control study in Italy.

Ursula KirchmayerChiara SorgeJanet SultanaFrancesco LapiGraziano OnderNera AgabitiSilvia CasciniGiuseppe RobertoGiovanni CorraoCristiana VitaleErsilia LucenteforteAlessandro MugelliMarina Davoli

Published in: Therapeutic advances in drug safety (2019)

BPs do not increase cardiovascular risk and can be prescribed to elderly patients for osteoporosis treatment. However, patients with pre-existing cerebrovascular/cardiovascular conditions should be carefully monitored.

Keyphrases

cardiovascular disease
postmenopausal women
type diabetes
middle aged
bone mineral density
cardiovascular risk factors
replacement therapy
coronary artery disease
body composition